This review aims to compile existing knowledge and identify gaps regarding the Trem2 signaling pathway in both atherosclerosis and cardiomyopathy, while also considering the potential for therapeutic modulation of TREM2 signaling in cardiovascular disease. The gene discussed is TREM2; the disease is cardiomyopathy.